Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Proposal for simplified 2-tier AE attribution system mandating baseline and longitudinal assessment, PROs w/ MM-specific symptom items, objective criteria for clinical significance of lab abnormalities and others”
Title: Toward more accurate adverse event attribution in multiple myeloma clinical trials
Authors: Manisha Bhutani, Peter M. Voorhees
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
